Foghorn Therapeutics Inc. (FHTX) Operating margin 2020–2025
Foghorn Therapeutics Inc. (FHTX) operating margin by fiscal year — reported operating income divided by reported revenue.
-279.5%FY2025 · since FY2020: -15937.4% → -279.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -279.5% | +174.8 pp |
| FY2024 | -454.3% | -138.4 pp |
| FY2023 | -315.9% | +293.3 pp |
| FY2022 | -609.2% | +7027.9 pp |
| FY2021 | -7637.1% | +8300.3 pp |
| FY2020 | -15937.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice